Continuous Blood Glucose Monitoring Systems Market

A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
Continuous Blood Glucose Monitoring Systems Market aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring Systems. Continuous Blood Glucose Monitoring Systems Market contains market size and forecasts of Continuous Blood Glucose Monitoring Systems in global, including the following market information:
Global Continuous Blood Glucose Monitoring Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Continuous Blood Glucose Monitoring Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Self-Monitoring Blood Glucose Systems Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Continuous Blood Glucose Monitoring Systems include Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen and Nipro, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Blood Glucose Monitoring Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Blood Glucose Monitoring Systems Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Continuous Blood Glucose Monitoring Systems Market Segment Percentages, by Type, 2022 (%)
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Global Continuous Blood Glucose Monitoring Systems Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Continuous Blood Glucose Monitoring Systems Market Segment Percentages, by Application, 2022 (%)
Self/Home Care
Hospital & Clinics
Global Continuous Blood Glucose Monitoring Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Continuous Blood Glucose Monitoring Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Blood Glucose Monitoring Systems revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Continuous Blood Glucose Monitoring Systems revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Continuous Blood Glucose Monitoring Systems, market overview.
Chapter 2: Global Continuous Blood Glucose Monitoring Systems market size in revenue.
Chapter 3: Detailed analysis of Continuous Blood Glucose Monitoring Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Continuous Blood Glucose Monitoring Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.